Drug Price Trends for NDC 58657-0525

Average Pharmacy Cost for 58657-0525

Drug Name	NDC	Price/Unit ($)	Unit	Date
M-PAP 160 MG/5 ML LIQUID	58657-0525-04	0.03972	ML	2024-12-18
M-PAP 160 MG/5 ML LIQUID	58657-0525-16	0.00924	ML	2024-12-18
M-PAP 160 MG/5 ML LIQUID	58657-0525-04	0.03986	ML	2024-11-20
M-PAP 160 MG/5 ML LIQUID	58657-0525-16	0.00835	ML	2024-11-20
M-PAP 160 MG/5 ML LIQUID	58657-0525-16	0.00956	ML	2024-10-23
M-PAP 160 MG/5 ML LIQUID	58657-0525-04	0.03888	ML	2024-10-23

Best Wholesale Price for NDC 58657-0525

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type

58657-0525 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 58657-0525

Introduction

The pharmaceutical market is dynamic and influenced by various factors, including regulatory changes, technological advancements, and economic conditions. Analyzing the market and projecting prices for a specific drug, such as the one identified by the National Drug Code (NDC) 58657-0525, requires a comprehensive understanding of these factors.

Understanding NDCs and Drug Pricing

• NDC Definition: The National Drug Code (NDC) is a unique identifier assigned to each drug product, including its strength, dosage form, and packaging[2].
• Pricing Metrics: Drug prices are often tracked using the Wholesale Acquisition Cost (WAC), which is the list price of a drug before any discounts or rebates are applied[2][5].

Current Pricing Trends

• Recent Price Increases: From January 2022 to January 2023, more than 4,200 drug products experienced price increases, with 46% of these increases exceeding the rate of inflation. The average price increase was 15.2%, translating to $590 per drug product[2].
• Category-Specific Increases: Price increases vary significantly between single-source and multi-source drugs. Single-source drugs saw an average increase of 7.4% ($958), while multi-source drugs had an average increase of 26.0% ($69)[2].

Methodology for Identifying Price Increases

• One-Year Price Increase: A drug is identified for review if its WAC unit price increases by 15% or more in any 12-month period. For example, if the current unit price as of January 1, 2023, is compared to the price 12 months prior, an increase of 15% or more would trigger a review[1].
• Three-Year Cumulative Increase: A 50% cumulative increase over three years also triggers a review. This is calculated by comparing the current unit price to the price three years prior[1].

Market Analysis for NDC 58657-0525

To analyze the market and project prices for the drug with NDC 58657-0525, we need to consider several factors:

Drug Specifics

• Drug Name and Type: Identifying the specific drug associated with NDC 58657-0525 is crucial. This information would typically include the drug's name, active ingredients, dosage form, and strength.
• Market Entry Date: Knowing when the drug entered the market helps in understanding its price history and any significant price changes over time[1].

Historical Price Data

• One-Year and Three-Year Price Changes: Analyze the WAC unit price changes over the past year and three years to determine if the drug has met the thresholds for review (15% one-year increase or 50% three-year cumulative increase)[1].
• Example Calculation: If the drug's WAC unit price increased from $100 to $115 over one year, this represents a 15% increase, which would meet the review threshold[1].

Market Dynamics

• Competitive Landscape: The presence of generic or biosimilar versions can impact pricing. For instance, if a generic version is available, it typically reduces the price of the brand-name drug[5].
• Regulatory Environment: Changes in regulatory policies can influence drug pricing. For example, evolving clinical trial designs and regulatory frameworks can affect the cost and efficiency of drug development[3].

Price Projections

Short-Term Projections

• Inflation and Economic Factors: Adjusting for inflation and considering economic conditions can help predict short-term price changes. However, drug prices often increase at rates higher than inflation[2][5].
• Recent Trends: Given the recent trend of average price increases exceeding inflation, it is likely that the drug with NDC 58657-0525 could see a similar increase if it follows the industry average.

Long-Term Projections

• Market Growth and Technological Advancements: The pharmaceutical market is projected to grow significantly, driven by factors such as increased R&D investments and the adoption of AI-based tools for drug discovery. This growth could lead to higher prices due to increased demand and development costs[4].
• Regulatory and Technological Innovations: Innovations in clinical trial designs and the rise of precision medicine could make drug development more efficient but may also lead to higher initial costs, which could be reflected in drug prices[3].

Impact of Generic and Biosimilar Drugs

• Generic and Biosimilar Pricing: Generic drugs typically have lower prices than their brand-name counterparts. If a generic version of the drug with NDC 58657-0525 is available, it would likely reduce the average price paid for the drug. For example, generic versions are often priced 62.26% lower than their brand equivalents[5].

Key Takeaways

• Price Increases: The drug with NDC 58657-0525 could experience price increases similar to industry averages, especially if it meets the review thresholds.
• Market Dynamics: The presence of generic or biosimilar versions and changes in regulatory policies can significantly impact pricing.
• Long-Term Growth: The pharmaceutical market's projected growth and technological advancements could influence long-term price projections.

FAQs

1. What is the significance of the Wholesale Acquisition Cost (WAC) in drug pricing?

   • The WAC is the list price of a drug before any discounts or rebates are applied, serving as a benchmark for tracking price changes.

2. How are price increases for prescription drugs typically tracked?

   • Price increases are tracked over specific periods, such as one year or three years, to identify significant changes that may trigger reviews.

3. What impact do generic drugs have on the pricing of brand-name drugs?

   • Generic drugs are typically priced lower than their brand-name counterparts, often reducing the average price paid for the drug.

4. How do regulatory changes affect drug pricing?

   • Regulatory changes can influence drug pricing by affecting the cost and efficiency of drug development and the approval process.

5. What role does AI play in the pharmaceutical market?

   • AI is emerging as a crucial tool in drug discovery, potentially making the development process more efficient but also contributing to higher initial costs.

Cited Sources

1. Methodology for Identifying Drugs for Affordability Review - HCA Washington State.
2. Changes in the List Prices of Prescription Drugs, 2017-2023 - ASPE.
3. 5 Predictions for the Biopharma and Biotech Industries in 2025 - TFS CRO.
4. US Pharmaceutical Market Review 2020-2023 and Forecast - GlobeNewswire.
5. MHDO Rx Transparency Report - Maine Health Data Organization.